News
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...
Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns
Eli Lilly's orforglipron reduced A1C and weight in type 2 diabetes, while weekly insulin efsitora matched daily insulin with ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...
Novo Nordisk reported mostly mild side effects from its experimental weight-loss drug CagriSema, though results upset ...
Eli Lilly's Mounjaro diabetes and weight-loss drug approved in India in KwikPen device, offering personalized treatment ...
1d
HealthDay on MSNDegree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk ImprovementFor adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results